DCM
JAZZ icon

Driehaus Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Driehaus Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-90,550
Closed -$11.2M – 460
2025
Q1 		$11.2M Buy
+90,550
New +$11.8M 0.11% 228
2018
Q4 		– Sell
-2,090
Closed -$351K – 463
2018
Q3 		$351K Sell
2,090
-5,035
-71% -$866K 0.01% 420
2018
Q2 		$1.23M Buy
+7,125
New +$1.16M 0.04% 321
2017
Q3 		– Sell
-8,953
Closed -$1.39M – 533
2017
Q2 		$1.39M Buy
8,953
+3,513
+65% +$537K 0.05% 303
2017
Q1 		$790K Buy
+5,440
New +$709K 0.03% 391
2015
Q1 		– Sell
-11,882
Closed -$1.95M – 520
2014
Q4 		$1.95M Sell
11,882
-54
-0.5% -$8.96K 0.08% 317
2014
Q3 		$1.92M Sell
11,936
-11,763
-50% -$1.81M 0.07% 335
2014
Q2 		$3.48M Buy
23,699
+11,441
+93% +$1.59M 0.11% 243
2014
Q1 		$1.7M Buy
12,258
+75
+0.6% +$11.3K 0.05% 355
2013
Q4 		$1.54M Sell
12,183
-36,580
-75% -$3.79M 0.06% 352
2013
Q3 		$4.49M Sell
48,763
-52,246
-52% -$4.21M 0.17% 178
2013
Q2 		$6.94M Buy
+101,009
New +$6.17M 0.3% 105

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Driehaus Capital Management's JAZZ Position: Q2 2025 in Review

Driehaus Capital Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 90,550 shares — an estimated $11.2M sold.

Driehaus Capital Management first reported a position in JAZZ in Q2 2013 and held it in 12 quarters. The position peaked at $11.2M in Q1 2025. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Driehaus Capital Management reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 90,550 Jazz Pharmaceuticals shares in Q2 2025, an estimated $11.2M.
  • Driehaus Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Driehaus Capital Management's Jazz Pharmaceuticals position peaked at $11.2M in Q1 2025.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Driehaus Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.